Rosuvastatin Unknown Status Phase 4 Trials for Angioplasty / Acute Coronary Syndromes (ACS) Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01245803Acute Rosuvastatin for Preventing Myocardial Damage in Patients With ACS
NCT02077257LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients